Stock Events

Orion 

€38.72
0
+€0+0% Friday 11:11

Statistics

Day High
38.72
Day Low
38.72
52W High
44.42
52W Low
36.57
Volume
40
Avg. Volume
18
Mkt Cap
-
P/E Ratio
-
Dividend Yield
4.13%
Dividend
1.6

Upcoming

Dividends

4.13%Dividend Yield
10Y Growth
2.1%
5Y Growth
1.99%
3Y Growth
2.17%
1Y Growth
6.67%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1ORNBV.MI. It's not an investment recommendation.

About

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company has a collaboration with Nanoform to apply Nanoform's CESS technology to new chemical entities. It serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) line of inhalers for asthma and COPD to Propeller's digital medicine platform. Orion Oyj is headquartered in Espoo, Finland.
Show more...
CEO
Mr. Timo Lappalainen
Employees
3447
Country
FI
ISIN
FI0009014377
WKN
000A0J3QM

Listings